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Effects of PBBs on Cattle. 111. Target
Organ Modification as Shown by Renal
Function and Liver Biochemistry
by F. L. Schanbacher,* L. B. Willett,* P. D. Moorhead,t
and H. D. Mercert
Efforts were made to more clearly delineate target organs and mechanisms of toxicity for PBBs in
cattle. Methods were developed to obtain sequential liver biopsies on bovine heifers which yield 0.5 to 1.0
g oftissue. PBB was fed at a dose of250mg/head/day to Holstein heifers for 202 days. This dose produced
noclinical signsoftoxicity in anyofthe heifers, yetthis produced tissue PBB concentration ofgreater than
100 times the FDA tolerance in body fat of0.3 ppm. Liver biopsies (0.5-1.0 g each) were taken at days 0,
90, and 180. The liver tissue was homogenized and microsomes were prepared. Dithionite difference
spectra were determined on the carbon monoxide treated microsome suspension and the cytochrome
P-450 content determined. Also, the 100,000g supernatant was saved for ornithine decarboxylase analysis
as a measure of hepatocyte proliferative activity. Results of the cytochrome P-450 analysis showed a
significant (p < 0.05) two-fold elevation (pergram ofwetliver) by day 90 and remained significantly (p <
0.05) elevated on day 180. The cytochrome P-450 values ofcontrol animals not receiving PBBs showed no
such increase with time. The biopsy procedure appeared not to adversely affect the liver cytochrome
P-450 concentration in the control heifers. These results show that PBBs at a dose of250 mg/day induced
the drug metabolism system ofthe liver, ofwhich the cytochrome P-450 is a part, indicating that the liver
is a potential target organ for PBBs. However, this has not been shown to cause clearsigns ofhepatotoxic-
ity in the cow as determined from histopathology or serum enzyme analyses. The observed elevation of
gross liver weights ofthe PBB-treated animals might be an expected consequence ofthecytochrome P-450
induction. In contrast to rodents, the kidney has been identified by histopathology as a target organ for
PBB toxicity in cattle. However, renal function studies with 'I1I-sodium-iodohippurate and 25sodium
iodothalaate in PBB treated cows indated that PBB toxicity to the kidney did not affect glomerular
filtration rate or effective renal plasma flow even though nephrotoxic effects were produced. From these
studies, both lver (as expected) and kidney (unexpected) were affected by PBBs. For liver this did not
result in hepatotoxicity while for kidney nephrotoxicity was produced but could not be mechanistically
explained.
Introduction
The continued controversy surrounding the ef-
fects and economic impact of chronic polybrom-
inated biphenyl (PBB) exposure in dairy cattle is at
least partially attributable to the virtual absence of
information regarding target organ specificity, me-
tabolism ofxenobiotic compounds in cattle, and the
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potential ramifications to human health via the food
chain.
After the impact of PBB contamination became
apparent (1), feeding trials were conducted that es-
tablished the PBB level required to elicit toxicity
and provided clinicopathological definition of the
toxicity syndrome (2-4). Histopathological studies
(3) together with the clinical chemistry ofthe blood
and urine of PBB treated dairy cattle (4), identified
affected tissues and suggested target organs. Renal
pathology was an outstanding consequence ofacute
PBB doses but was not evident at lower chronic
doses. Histopathological alterations of liver were
evident at acute PBB doses but were not as pro-
nounced as the renal lesions (4). However, hepatic
April 1978 119alteration was also evident at lower chronic doses of
PBB (2). These results suggested that both liver and
kidney were target organs for PBB toxicity.
Although liver has been described as a common
target organ for other halogenated hydrocarbons
(5), at the time these studies were initiated, there
was only one report of hepatic response in PBB
treated rats (6). During the course of these studies,
subsequent reports also described the hepatotoxic
effects of PBB in rats (7-9).
We initiated multifaceted studies aimed at iden-
tifying target organs for PBB toxicity and potential
mechanisms of toxicity in dairy cattle. Fur-
thermore, any identification of target organ re-
sponses could be related to previously determined
clearance and distribution factors, histopathological
changes, and tissue concentration of PBB in the
dairy cow, relationships difficult to make in rats.
For assessment ofhepatic involvement, a dose of
250 mg PBB/day was chosen as the optimum de-
fined dose which appeared likely to elicit hepatic
effects [liver weight was elevated by this dose (2)]
without producing acute toxicosis having additional
clinical effects (i.e., feed intake, nutrition, renal in-
volvement, etc.) which would confound the in-
terpretation of results (2-4). Hepatic microsome
and cytochrome P-450 content were chosen as pa-
rameters indicative of specific hepatic response to
xenobiotic compounds (5). Hepatic ornithine de-
carboxylase activity was chosen as a measure of
post-injury cellular proliferation in the PBB treated
liver (10). For assessment of renal effects, renal
function (11) was determined at acute PBB doses
known to elicit pathological lesions ofthe kidney (3,
4, 11). Serum protein patterns were assessed in
cows and calves in an effort to detect both
nonspecific and specific organ and tissue effects of
PBB exposure. The results of these studies are
summarized in this paper.
Materials and Methods
Specific reagents used in tissue preparations or
assays were from the following sources:
ethylenediaminetetraacetic acid disodium salt and
sodium dithionite (J. T. Baker Co.); dithiothreitol
and pyridoxal phosphate monohydrate (A grade,
Calbiochem); aminooxyacetic acid hemihydro-
chloride, Grade II, semicarbazide hydrochloride,
and L-ornithine hydrochloride, Sigma grade (Sigma
Chemical Co.); DL-ornithine monohydrochloride
(1-14C) (49.9 mCi/mmole) (New England Nuclear).
The PBB was a commercial mixture of PBB (Fire-
Master BP-6, lot 6244 A, Michigan Chemical Co.)
containing predominantly hexabromobiphenyl but
also containing substantial penta- and hepta-
bromobiphenyls. All other general reagents used
were the best obtainable grade.
Liver samples (0.5-1.0 g) were obtained by
biopsy of dairy heifers before dosing and at 90 and
180 days after the start of the PBB dosing period.
Experimental heifers (400 kg each) were dosed daily
with 250 mg FireMaster BP-6 (lot 6244A) in gelatin
capsules for 202 days. Finely ground FireMaster
BP-6 was mixed with ground corn to prevent caking
and administered orally in gelatin capsules. Control
heifers matched in size and age, were biopsied at
the same time and received no PBB.
Each liver biopsy specimen was immediately fro-
zen at -70°C after biopsy and stored frozen (-20°C)
until homogenized. An individual homogenate was
prepared from 0.5-0.7 g of liver biopsy specimen
after removing clots, connective tissue, and dam-
aged tissue by teasing and washing with cold
isotonic saline. All biopsies from an individual cow
were homogenized on the same day.
Homogenates consisted ofone part minced tissue
(weight) plus four parts (volume) ofcold homogeni-
zation buffer (0.25 mM KPO4, pH 7.3 containing S
mM Na EDTA and 10 mM dithionite) and were
done in a Duall 23 conical glass tissue homogenizer
with a motor-driven Teflon pestle (Kontes) im-
mersed in ice. Five passes were made at medium
motor speed. A 50 ,ul aliquot of the crude homoge-
nate was saved for protein determination. The re-
maining crude homogenate was centrifuged at
l0,OOOg, 2°C, for 25 min. The supernatant was then
centrifuged at 100,000g, 2°C, for 60 min. The
l00,OOOg supematant was frozen until ornithine de-
carboxylase and proteinassays could be done. The mi-
crosomal pellet from the l00,OOOg centrifugation
was resuspended by gentle rehomogenization in 1.5
ml of cold 1.15% KCI and again centrifuged at
100,000g, 2°C, for 60 min. The washed microsomal
pellet was again resuspended as before in 1.5 ml of
1.15% KCI and stored overnight at 2°C until cyto-
chrome spectra could be run the next day.
Cytochrome P-450 was quantitated by dithionite
difference spectra of carbon monoxide treated mi-
crosomes as described by Matsubara (12). Aliquots
(0.1 and 0.15 ml) of microsome suspension ap-
proximately equivalent to that from 33 or 50 mg
whole liver (ca 0.5-0.75 mg MIC protein/ml) were
diluted to 1.0 ml with 1.15% KCI and bubbled for 2
min with carbon monoxide. After transfer to both
sample and reference spectrophotometer cuvets, 5
mg dithionite was added to the sample cuvet and the
difference spectrum determined after 1 min by
scanning in a Beckman DB-GT double-beam spec-
trophotometer with recorder. For quantitation of
cytochrome P-450, the molar extinction difference
of 104 mM-' cm-' between 450 and 490 nm was
used (12).
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by measuring "4CO2 liberated from D,L-(l-'4C)-or-
nithine. The assay, modified from Morley (13, 14),
contained 0.2 mM pyridoxal phosphate, 25 mM
potassium phosphate, pH 7.3, 2.5 mM dithio-
threitol, 0.01 mM aminooxyacetate, and 150 or 300
,41 of 100,000g supernatant preparation in 0.5 ml
total assay volume. Aminooxyacetate inhibited
nonspecific decarboxylation of ornithine (15).
Reaction was initiated by the addition of0.1 ,uCi of
'4C-ornithine (final assay concentration = 0.36
mM). Reactions were routinely incubated in septum
stoppered culture tubes for 2 hr at 37°C after which
the reaction was stopped by the addition with vor-
tex mixing of 0.25 ml of 4M citric acid to liberate
14C02. An additional 1 hr incubation allowed com-
plete release of 14CO2. The released "4CO2 was
trapped in 0.3 ml of ethanolamine:methylcellosolve
(1:2, v/v) contained in a polyethylene trap (Kontes)
suspended from the rubber septum stopper. The
entire trap and its contents were counted by liquid
scintillation. Blank reactions complete with all
assay components and enzyme preparation were in-
cubated for the same time as the assays but con-
tained 1.0 mM semicarbazide, an inhibitor of or-
nithine metabolism (13).
Under these conditions, the reaction was linear
for at least 2 hr. Liver homogenate prepared from a
thioacetamide-treated guinea pig (150 mg/kg) (16) in
which ornithine decarboxylase was elevated ap-
proximately 400-fold over that of untreated liver
served as a positive control with each set ofassays.
The homogenization buffer used prevented loss
ofornithine decarboxylase activity and at the same
time was found to give identical cytochrome P450
yields as 1.15% KCI (12). The washing of micro-
somes by resedimentation in 1.15% KCI was neces-
sary in order to remove dithiothreitol which inter-
ferred with cytochrome P-450 spectral analysis.
Hence with this single homogenization both or-
nithine decarboxylase and cytochrome P-450 could
be quantitated. With this procedure microsome
preparations were stable up to 2 days at 2°C while
ornithine decarboxylase activity in the first
100,OOOg supernatant fluid was stable for months at
-200C.
Protein was quantitated by the Lowry method
(17) with corrections for slight interference by
dithiothreitol. Serum protein electrophoretic pro-
files were determined for all heifers of this experi-
ment plus heifers of previous experiments in which
the dose was 25 g PBB/day (4) and in calves from
heifers given 250 mg PBB/day (18). Polyacrylamide
slab gel electrophoresis of serum proteins used Iso-
pore 5-20%o acrylamide linear gradient precast gels
(Isolab, Inc.) with 50 mM Tris adjusted to pH 9.00
with glycine as the tank buffer in an Ortec elec-
trophoresis apparatus and pulsed power supply.
Protein was visualized in the gel by staining with
0.2% Coomassie Brilliant Blue R-250 in glacial ace-
tic acid:methanol:water (10:45:45), and diffusion
destaining in the same solution without dye (Ortec
Application Note AN 32).
Results
Clinical Toxicity
It should be stressed that during this experiment
the feeding ofPBB as FireMaster BP-6, 250/mg day
for 202 days, to dairy heifers produced no clinical
evidence of toxicity. Durst et al. (2) have also pre-
viously shown this to be a nontoxic dose in contrast
to 25 g/day for 32 to 60 days which produced rapid
and severe toxicosis (2, 3).
Liver Cytochrome P-450
The relative microsome content of liver biopsies
is shown in Figure 1. There was an apparent relative
increase in the weight of microsomal protein per
weight of liver protein after treatment in the PBB-
treated heifers, although the standard errors of the
controls and ofthe PBB-treated heifers overlapped.
This would suggest that the microsome content of
the liver was increased by PBB treatment. The
same pattern was seen when the absolute concen-
trations were compared rather than the relative
changes as in Figure 1.
PBB treatment produced a clear elevation of the
cytochrome P-450 content of liver microsomes as
shown in Figure 2. There was at least a 50o in-
crease in cytochrome P450 content of liver micro-
somes in PBB-treated heifers by day 90. Further,
the cytochrome content remained elevated through
180 days of treatment.
The elevation in liver cytochrome content in PBB
treated heifers was even more pronounced when
expressed on a per gram wet liver basis (Fig. 3),
amounting to at least a twofold increase by day 90,
but declining somewhat by day 180. This, together
with results shown in Figure 2, indicate that the
PBB treatment at 250 mg/day clearly induced cyto-
chrome P450 to increase in liver microsomes and
that an even greater increase occurred in whole tis-
sue. It seems likely that there was also a real eleva-
tion oftotal tissue microsome content, as suggested
from Figure 1, in addition to a specific increase in
the cytochrome P450 content ofthose microsomes.
This would account for the relative change in cyto-
chrome P450 content of whole tissue exceeding
significantly the relative change in cytochrome
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FIGURE 1. Relative change in liver microsome content of PBB
treated and control heifers. Values shown are percent of the
day zero (predosing) value per weight (mg) microsomal pro-
tein per weight (mg) liver protein for each group: (o) PBB-
treated heifers, receiving 250 mg/day for 202 days; (.) con-
trols received no PBB.
P450 content of microsomes alone.
The ability of PBB to induce liver cytochrome
P-450 is clearly illustrated in Figure 4, where the
cytochrome P-450 content of liver microsomes is
compared to the whole plasma PBB concentration
of the treated heifers (19). The correlation coeffi-
cient was 0.91. Further, the basal values for micro-
somal cytochrome P-450 content are comparable to
those found for unstimulated rat liver while the
levels induced by PBB are comparable in terms of
both relative increase and absolute concentration to
those of rat liver after maximal induction with PBB
(7) or phenobarbital (12).
Liver Ornithine Decarboxylase
While there was a clear elevation ofhepatic cyto-
chrome P-450 content by PBB, there was no such
increase in hepatic ornithine decarboxylase activ-
ity. As shown in Figure 5, there was no detectable
ornithine decarboxylase activity in either PBB-
treated or control heifers at any time period exam-
ined. This was not due to assay insensitivity since
basal ornithine decarboxylase activity in normal
guinea pig liver was approximately 2 pmole 14CO2/
FIGURE 2. Relative change in cytochrome P-450 content of liver
microsomes for PBB-treated and control heifers. Values
shown are percent of the day zero (predosing) value for
nmoles cytochrome P-450 per mg microsomal protein in (o)
PBB-treated (250 mg/day) and (X) control heifers.
hr/mg liver protein with these same assay condi-
tions. In our hands treatment of guinea pigs with
thioacetamide (150 mg/kg IP) (15) resulted in a
readily detectable 375-fold increase in liver or-
nithine decarboxylase activity to about 750 pmole
CO2hr/mg protein by 24 hr. Further, all ornithine
decarboxylase assays done on bovine liver in-
cluded, as a positive control, assays of thioaceta-
mide treated guinea pig liver preparations. Ac-
tivities obtained are shown in Figure 5 as an indica-
tion of what might be expected in the event of he-
patic ornithine decarboxylase stimulation. It ap-
pears from this that the bovine liver has very low
ornithine decarboxylase activity and it is clearly not
significantly elevated by 250 mg PBB/day.
Renal Modification
The treatment ofcows with high levels ofPBB (25
g/day) was previously shown to produce un-
equivocal clinical toxicity (2) with characteristic
histopathological lesions (3). Among the primary le-
sions observed was renal failure accompanied by
extreme dilatation of collecting ducts and convo-
luted tubules with epithelial changes of hydropic
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FIGURE 3. Relative change in cytochrome P-450 concentration of
whole liver. Values shown are percent of the day zero (pre-
dosing) value for nmoles cytochrome P-450 pergram wet liver
in (o) PBB-treated (250 mg/day) and (.) control heifers.
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FIGURE 4. Correlation ofplasma PBB concentration with hepatic
microsomal cytochrome P-450 content in PBB-treated heif-
ers. PBB was determined as previously described (18) in
whole plasma from PBB-treated (250 mg/day) heifers at 0
(predosing), 90, or 180 days of dosing. Correlation co-
efficient r = 0.91.
degeneration and separation from the basement
membrane (3). This would strongly suggest that
renal function should be seriously impaired as a
consequence of PBB toxicosis. However, recent
efforts to determine the extent and site ofsuch renal
impairment through renal function studies during
PBB toxicosis (II) gave no evidence ofimpairment.
Typical bovine renal function parameters are
shown in Table 1 and are essentially the same for
both PBB treated and control cows. After approxi-
mately 60 days, including 25 days ofPBB treatment,
the glomerular filtration rate and effective renal
plasma flow remained normal (II). This indicates
that in spite of the previously described renal le-
sions there is either (a) no impairment by PBB of
either the glomerular filtration process or of the ac-
tive transport processes or (b) the bovine kidney
has virtually unlimited compensatory capacity in
the event of nephron damage.
Serum Protein Changes
Upon electrophoretic analysis ofserum protein in
PBB treated heifers, there was no change in the
protein pattern following treatment at doses of 250
mg/day or below for 60 days. In contrast, treatment
with 25 g/day (2) caused significant changes in
serum protein electrophoretic patterns. The
changes are typified in Figure 6. Within 15 days
after the first PBB dose was given, significant pro-
tein alterations were evident. Specifically the pre-
albumin band (the fastest migrating band) was mark-
edly elevated on day 15 and increased thereafter.
Conversely, serum albumin appeared to decrease
somewhat on days 30 and 40. A band immediately
below serum albumin did not stain with Coomassie
Blue and hence was visualized by the "negative'
staining characteristics. While this band has not
been positively identified, its relative migration and
staining characteristics suggest that it might be a,-
acid glycoprotein, an acute phase glycoprotein
made by the liver during infection or febrile trauma,
etc. (20). This band was markedly elevated on days
30, and 40. By day 30, SLDH and SGOT were also
markedly elevated in this cow (4). There was also a
slight increase in a-globulins (between transferrin
and serum albumin) from days 15 through 40. Hence
high PBB doses alter serum protein composition
and it appears that those proteins of hepatic origin
are primarily involved.
Newborn calves show dramatic changes in serum
protein composition as a result ofgut absorption of
ingested colostrum immunoglobulins shortly after
birth. A typical pattern is shown in Figure 7 for a
newborn calf whose dam received 250 mg PBB/day
for 60 days while pregnant. This pattern is indistin-
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FIGURE 5. Failure of ornithine decarboxylase activities to in-
crease in PBB-treated and control heifers. Microsomal cyto-
chrome P-450 for (o) PBB-treated (250 mg/day) and (e) con-
trol heifers is shown for comparison. Ornithine decar-
boxylase activities for both (o) PBB-treated and (i) control
heifers were not distinguishable from the reaction blanks in
all samples tested. Activity of control assays with
thioacetamide treated guinea pig liver is indicated by the
arrow.
Table 1. Renal function parameters before and after PBB dosing
in treated and control cows."
Glomerular Effective renal
Daily PBB filtration rate, plasma flow
Cow dose, gb Trial mI/kg/min mVkg/min
A 25 Predose 3.5 10.1
Final 3.4 12.6
C 25 Predose 2.7 7.5
Final 2.8 14.0
B 0 Predose
Final 2.6 9.1
D 0 Predose 2.2 6.7
Final 2.3 8.6
°Data are for initial and final of six renal function trials (days
0, 9, 15, 29, 49, 62-65).
b PBB dose given daily for 25 days. Predose trial is day 0 while
final trial is 35 ± I days after the last dose for all cows.
guishable from that ofacalfnot receiving PBB. This
calfshowed a typical neonatal bovine serum protein
pattern on day 1 prior to ingestion of colostrum.
This pattern is characterized by the paucity of im-
munoglobulin in the serum. In contrast, by the sec-
ond sampling period, the calf had ingested co-
lostrum and transfer from the gut to blood had oc-
curred. There appeared to be no impairment of gut
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FIGURE 6. Electrophoretic profiles of serum protein in a typical
dairy heifer treated with 25 g PBB/day. Days shown are days
of PBB dosing, -7 and - I being samples taken predosing. At
day 40, cow 24 was moribund from toxicosis, and necropsy
was performed on day 41. Electrophoresis was done with
5-20%. linear gradient polyacrylamide slab gels at pH 9.0.
Reference samples of normal control adult serum (NCS) and
commercial fetal calf serum (FCS) were also run.
mediated uptake of colostral immunoglobulins as a
result of PBB exposure in utero. The subsequent
protein patterns are normal for the growing calf.
This pattern also indicates that maternal exposure
to PBB at 250 mg/day does not alter the transfer of
immunoglobulins into mammary secretion (colos-
trum) from serum.
Discussion
These studies show that PBB induced hepatic
cytochrome P-450 synthesis in the bovine (Figs. 2
and 3) which was correlated with plasma PBB con-
centration (Fig. 4). This induction of cytochrome
P-450 was probably accompanied by a small but real
increase in microsome content of liver tissue (Fig.
1). These increases occurred with a PBB dose of250
mg/day, which produced no clinical sign of toxicity
in the treated heifers, even though the dose was
administered for 202 days. Similar induction of he-
patic microsomes and cytochrome P-450 was found
in rats also given this same PBB mixture, Fire-
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FIGURE 7. Electrophoretic profiles of serum protein in a typical
calf exposed to PBB in utero. Calf 115 was exposed to PBB
while in utero by dosing the dam with 250 mg/day for 60 days
in the first trimester of pregnancy. Blood samples were taken
at the indicated days of age (day I = day of birth), the day I
sample being taken prior to first nursing of colostrum. The
calf was fed PBB contaminated colostrum or milk from its
own dam until weaned at 42 days of age. The colostrum or
milk was contaminated with PBB which had been previously
administered to the dam during pregnancy as described above
and entered mammary secretions as a result of increased
clearance associated with onset of lactation and utilization of
body fat.
Master BP-6 (7, 8) and in rats given only hexa-
bromobiphenyl (6).
In contrast to the elevation of cytochrome P-450
and microsomes of liver upon exposure to PBB,
there was no increase in hepatic ornithine decar-
boxylase activity. Byus et al. (21) reported that PBB
as well as 2-methylcholanthrene increased both or-
nithine decarboxylase and cytochrome P-450 in
liver of treated rats. A dramatic increase in or-
nithine decarboxylase is one of the earliest detecta-
ble events leading to cellular proliferation or rapid
growth such as occurs in regenerating liver follow-
ing hepatoinjury (16, 22, 23). If elevated ornithine
decarboxylase activity is indicative of cellular pro-
liferation in regenerating liver, then it appears that
in dairy heifers 250 mg PBB/day did not induce de-
tectable hepatoinjury or liver cell proliferation even
though hepatic microsomes and cytochrome P-450
were elevated.
From this, it appears that in the dairy heifer in-
duction of hepatic microsomes and cytochrome
P-450 by PBB is dissociated from hepatocyte prolif-
eration and precedes toxicity. Hence, as has been
pointed out by others, elevated microsome and cy-
tochrome P-450 content of liver is not necessarily
indicative of hepatotoxicity by a xenobiotic com-
pound (24). The conclusion drawn from these
y-GLOB- biochemical analyses that 250 mg PBB/day is not
ULINS hepatotoxic in dairy heifers is also supported by the
clinical diagnosis for these same heifers; no evi-
dence of toxicosis was found in this and a previous
study (4).
At higher doses of PBB (25 g FireMaster BP-6/
day) there was clear evidence oftoxicity which was
lethal (2, 12). At necropsy, histopathological studies
of various organs showed, for the liver, enlarge-
ment, glycogen depletion of hepatocytes, and
sinusoidal dilatation in the liver; and for the kidney,
extreme dilatation of collecting ducts and convo-
luted tubules, with tubular epithelial degenerative
changes marked by cloudy swelling, hydropic de-
generation, and separation from the basement
membrane (3). It is unfortunate that no liver tissue
was available from these heifers during toxicosis
such that microsome and cytochrome P-450 con-
tent, and ornithine decarboxylase activity could be
examined. For the kidney, in spite of marked his-
topathological deterioration (3), there was no alter-
ation in renal function (11) (Table 1). This was a
surprising observation and leaves the site and
mechanism of renal toxicity by PBB (FireMaster
BP-6) undetermined. There is no question that the
kidney is a target organ with high levels of PBB
exposure.
The serum protein electrophoretic patterns of
heifers given 25 g PBB/day for 32-60 days showed
significant alteration. Specifically, the serum albu-
min concentration appeared to decrease while
prealbumins and a protein tentatively identified as
a,-acid glycoprotein increased. Both changes oc-
curred during periods ofelevated SGOT and SLDH
(4). There was also a tendency for serum albumin to
decline in these heifers during this same period as
determined by blood chemical analyses (4), thus
supporting the conclusions drawn from the elec-
trophoretic profiles of serum protein in this study.
The significance ofchanges in a,-acid glycoprotein,
an acute phase serum glycoprotein made by the
liver in response to infection trauma (20), and pre-
albumin is not known at this time, although these
changes are probably a further indication ofthejury
to the liver by high doses of PBB. It is interesting
that all of the serum proteins which thus far appear
altered by high PBB doses are made by the liver.
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125Lloyd et al. (25) showed a depression in rate of
albumin synthesis after partial hepatectomy which
was considered to result from a shift in protein
synthesis by the hepatocyte away from secreted
proteins and toward intracellular protein during
post-injury hepatocyte proliferation. Jamieson and
Ashton (20) describe the increased synthesis and
secretion of a,-acid glycoprotein during liver in-
flammation. It is generally thought that the in situ
tissue damage of inflammation causes increased he-
patic synthesis of acute phase proteins (19). The
role of elevated a,-acid glycoprotein in acute phase
inflammatory responses is unknown, although from
these results it appears that xenobiotics in toxic
amounts may influence those aspects of the inflam-
matory responses mediated by the liver. This find-
ing may have ramifications to aspects of disease
resistance or immunosurveillance, although we
would not expect these ramifications, if indeed
there are any, in doses below those producing out-
right toxicosis with hepatoinjury. This area cer-
tainly merits further study for the mechanisms un-
derlying these observations may have important
ramifications to both animal and human health ef-
fects of xenobiotics.
There was no apparent impairment of the ability
ofthe intestinal mucosa ofcalves exposed to PBB in
utero to transport immunoglobulin into blood as
evidenced by the normal electrophoretic pattern of
colostrum immunoglobulin absorption into the
blood (Fig. 7). The dams of these calves received
250 mg PBB/day or less, doses which have pro-
duced no signs of toxicosis in any animal receiving
it. It is difficult to assess the in utero dose received
by the calfalthough substantial amounts ofPBBs do
cross the placenta to enter the fetus (26). Poly-
chlorinated biphenyls were shown to enter the fetus
and elevate aryl hydrocarbon hydroxylase and
cytochrome P-450 or fetal liver (27). Thus the fetus
is clearly susceptible to xenobiotic toxicosis in
utero or at birth. Others have shown that the intes-
tinal mucosa itself has inducible aryl hydrocarbon
hydroxylase activity and that this activity is not in-
duced by PCB (28), indicating that the drug
metabolizing system of intestinal mucosa is suscep-
tible to xenobiotic toxicosis but is different in its
control from that of liver. Hence one might expect
different tissue sensitivities and responses to
xenobiotics. Further, the ingestion of certain
xenobiotics may directly affect intestinal mucosa
and alter gut function. This apparently did not hap-
pen in calves exposed to PBB in utero whose dams
received 250 mg PBB/day or less or who sub-
sequently ingested PBB contamined colostrum from
the dam. The absorption of immunoglobulin from
ingested colostrum into the serum of the calf also
appeared to provide sufficient serum immuno-
globulin levels to confer passive immunity to the
calf.
In summary, we have shown that feeding 250 mg
PBB/day to dairy heifers induced increases in the
hepatic microsomes and cytochrome P-450 but
showed no evidence of inducing hepatocyte pro-
liferative activity as assessed by liver ornithine de-
carboxylase activities. Hence, elevation of liver
cytochrome P-450 and microsome content cannot
be interpreted as evidence of hepatic injury or tox-
icity at this level ofPBB. However, at higher doses
of PBB (25 g/day) there is evidence for hepatic in-
jury as shown by gross pathology (2, 4), his-
topathology (8), and biochemical evidence as re-
flected in altered serum protein content for those
serum proteins made by the liver (Fig. 6).
There was evidence of renal toxicity at only the
high dose of PBB (25 g/day) but this was not re-
flected by reduced renal function (Table 1). Thus
the kidney was clearly a target organ for PBB tox-
icity but the mechanism and site could not be iden-
tified from our studies. In addition, there was no
evidence for gastrointestinal toxicity by PBB as ex-
amined in calves exposed to PBB in utero (Fig. 7),
even though the gut is a potential target organ (28)
and did show histopathological lesions in cows re-
ceiving 25 g PBB/day (3).
Thus at PBB exposures of 250 mg/day or less,
there was no evidence for hepatic, renal, or intesti-
nal toxicity in the dairy heifer. At exposures of25 g
PBB/day toxicity was readily apparent in liver and
kidney and deterioration was rapid. These data
support the previous conclusion by Durst et al. (4)
that PBB is a threshold toxin (29) in cattle and must
be encountered in high concentrations before toxic
responses are elicited. Other related work on the
effects of PBBs in cattle is summarized in the ac-
companying papers (18, 30, 31). From these studies,
it is apparent that large animals are useful and reli-
able for studying xenobiotic effect, distribution, and
clearance. They may also serve to elucidate basic
mechanisms of xenobiotic activities which will be
useful in understanding their impact on human
health.
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